a Refacto tool
AdvertisementYour banner here · 728 × 90 · ads@refacto.app

← Explore · Market KXFDAVERVE102-VERV-32JAN01

Will the FDA approve VERVE-102 before Jan 1, 2032?

72.5% implied · bid 69.0¢ · ask 76.0¢

☆ Log in to track

A · Price & probability

The market prices this at 76.0%, flat over 24h, on a 7.0¢ spread.

Implied probability76.0%
Bid / ask / mid69.0¢ / 76.0¢ / 72.5¢
Spread7.0¢ (9.7%)
Change 24hn/a
Change 7dn/a

B · Liquidity & flow

Thin (score 15/100) — trade small; large orders will move the price. Order book leans 21% to the ask (sellers).

Volume 24h$0
Depth ±5¢ (bid/ask)$343 / $380
Imbalance21% bid
Large trades (>$1k)0
Liquidity score15.4 / 100

C · Momentum & volatility

RSI 50 (neutral); price is above its 7-day mean by 0.0σ — normal range.

Z-score vs 7d mean0.00
RSI (14, hourly)50.0
Realized vol 7d0.00pt
Change 1hn/a

E · Time & structure

Resolves in 3041d 6h.

Time to resolve3041d 6h
Resolution sourcemanual-review
Sum of outcomes100.0%

Price history

No price history yet.

Probability timeline

No history yet.

Order-book depth